New Stock Debut | Sinopec Medical-B (02591.HK) debuts on the market, opening 285.44% higher in the morning session. Its core product, Yisupagreptide , was approved for listing in January this year.
According to the Zhito Financial APP, Yinuo Medicine-B (02591.HK) has been listed for the first time. The announcement shows that the price per share is HK$18.68, with a total of 36,556,400 shares issued. The net proceeds amount to approximately HK$634.7 million. As of the time of writing, the stock has risen by 285.44% to HK$72, with a trading volume of HK$3 billion.
Latest